food industry glp 1 Boom in GLP-1 drugs augurs disruption How GLP-1 Medications Are Driving

MPs and NPs cause intestinal dysbiosis, a marked decrease in abundance of immune function-associated bacteria (42), an increase in the number of pathogenic bacterial colonies and a decrease in the number of CD4+ T helper 17 and regulatory T cells, leading to an immune imbalance, as well as an increase in plasma lipopolysaccharides (57), which stimulate intestinal inflammation (41)

Full trial-reported timeline by phase and use case

Policy Trichotillomania (TTM) is a mental health condition where you repeatedly and frequently pull out your own hair

It tells your fibroblasts, the cells responsible for producing collagen, to get to work

One of the main ways it works is by slowing gastric emptying, which means food stays in your stomach longer than you're used to